Edwards Lifesciences (EW) Other Non Operating Income (2015 - 2026)

Edwards Lifesciences' Other Non Operating Income history runs 12 years deep, the most recent figure standing at $71.5 million for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 2650.0% year-over-year to $71.5 million; the TTM figure through Mar 2026 stood at $76.1 million (up 15.65% YoY), while the FY2025 annual figure was $7.2 million, down 89.55% from the prior year.
• Other Non Operating Income was $71.5 million for Q1 2026 at Edwards Lifesciences, up from $3.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $71.5 million in Q1 2026 to a low of -$3.3 million in Q1 2022.
• Historically, Other Non Operating Income has averaged $9.8 million across 5 years, with a median of $3.2 million in 2025.
• The sharpest annual moves came in 2022 and 2026: Other Non Operating Income slumped 242.86% in 2022, then surged 2650.0% in 2026.
• A 5-year view of Other Non Operating Income shows it stood at $5.8 million in 2022, then plunged by 37.93% to $3.6 million in 2023, then jumped by 825.0% to $33.3 million in 2024, then tumbled by 90.39% to $3.2 million in 2025, then surged by 2134.38% to $71.5 million in 2026.
• The last three Other Non Operating Income figures came in at $71.5 million (Q1 2026), $3.2 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.